Sign in
4

Changes in Ownership

Olema Oncology, Inc. Filed Acc 0001831410-25-000007

Director sold 2,881 shares at $28.53 ($82,195)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harmon Cyrus Director 2025-12-22 Sale −2,881 $28.53 $82,195 741,259 D: show line 1 in the form
Open-market sales · 2,881 sh · avg $28.53 · $82,195
Loading xslF345X05/form4-12292025_091201.xml…